Stocks · Health care · Pharmaceutical Preparations

Johnson & Johnson

JNJ Clue Score64
United States Fiscal year ends January CIK 0000200406 Results filed 13 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Kathryn E Wengel
6 Feb 2026
EVP, Chief TO and Risk Officer
Exercised, kept
38,945
$101.87
$3.97M
Kristen Mulholland
6 Feb 2026
EVP, Chief HR Officer
Exercised, kept
5,625
$101.87
$573.02K
Timothy Schmid
6 Feb 2026
EVP, WW Chair, MedTech
Exercised, kept
15,571
$101.87
$1.59M
Elizabeth Forminard
5 Feb 2026
EVP, Chief Legal Officer
Exercised, kept
8,921
$129.51
$1.16M

What was left out

Form 4 filings counted 60
Amendments (4/A) skipped 1
Filings about a different issuer 4
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 22
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 903,945
History held since 3 Oct 2006